Acuta Capital Partners’s Surrozen SRZN Stock Holding History
Bought
Maintained
Sold
Other funds holding SRZN
CG
TCM
BCM
VA
SC
SSC
B
5VM
KCM
Acuta Capital Partners's SRZN Position: Q1 2026 in Review
Acuta Capital Partners reduced its Surrozen (SRZN) stake by 3.1% in Q1 2026, selling an estimated $133K and leaving 172,847 shares worth $5.04M. The position accounts for 3.55% of the portfolio, ranked #8.
Acuta Capital Partners first reported a position in SRZN in Q1 2025 and has held it in 5 quarters since. 59 funds tracked by Wall St. Rank hold SRZN as of Q1 2026.
- Acuta Capital Partners held 172,847 shares of Surrozen worth $5.04M as of Q1 2026.
- Acuta Capital Partners sold 5,568 Surrozen shares in Q1 2026, an estimated $133K.
- Surrozen made up 3.55% of Acuta Capital Partners's portfolio in Q1 2026, its #8 holding.
- Acuta Capital Partners first reported a position in Surrozen in Q1 2025 and has held it in 5 quarters since.
- 59 funds tracked by Wall St. Rank held Surrozen as of Q1 2026.
Based on Acuta Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.